3 Canadian Healthcare Stocks With Earnings Growth Up To 128%

Healthcare costs are back in the political spotlight after Democrats won control of Congress on a platform focused on affordability, including medical bills. That puts pressure on policymakers to scrutinise pricing and efficiency, which often rewards Canadian healthcare businesses with solid finances and resilient demand. This article walks through three stocks from our Canadian healthcare quality screener that aim to combine financial strength with durable, real world demand.

The three Canadian healthcare stocks below are only a sample from our quality screen. The broader filter surfaced two other businesses with equally compelling stories that are not covered here.

If you want to identify stronger balance sheets, analyze cash generation, and focus on higher conviction ideas in this space, head straight to the Best Healthcare Stocks screener.

Aurora Cannabis (TSX:ACB)

Aurora Cannabis is primarily a medical-focused cannabis producer, supplying pharmaceutical grade products and related pharmacy services that line up cleanly with the healthcare theme, while still running a wider consumer business alongside that core activity.

Aurora Cannabis generated about CA$314 million from cannabis products across medical and consumer formats, and has a market value of roughly CA$474 million, which keeps it squarely in small cap territory for investors looking at focused healthcare exposure.

For healthcare investors, the appeal in Aurora Cannabis is its tilt toward regulated medical cannabis products and patient services, which puts product quality, compliance, and earnings resilience at the centre of the story.

"Completion of the Leuna expansion in the first half of fiscal 2027, combined with the rollout of proprietary cultivars, could reposition Aurora Cannabis from a constrained supplier into a larger scale and more efficient in country producer in Germany, which would directly influence international revenue and operating margin mix."

What happens if that shift in mix reshapes pricing power and earnings quality more than headline growth over the next few years?

If that earnings mix really does start to decouple, read the full narrative for Aurora Cannabis to see what the full thesis says about risks, pricing power, and patient demand.

Vitalhub (TSX:VHI)

Vitalhub leans directly into the Best Healthcare Stocks theme through its hospital patient flow tools and electronic health record and care coordination platforms, earning all of its roughly CA$127 million in revenue from healthcare software, with a market value near CA$493 million.

Vitalhub matters here because its software sits inside hospitals and community providers, shaping how patients move through the system and how clinicians document care. The next leg of the story rests heavily on how effectively it turns that footprint into deeper, stickier contracts over time.

"AI enabled products, including imaging referral protocoling, transcription and scribing for community services and internal code refactoring, provide new functionality to win and expand contracts while also targeting lower development and support costs."

The real swing factor is whether one emerging pressure on demand quietly caps how far those software driven efficiency gains can lift margins and growth.

If that pressure is building, the full narrative for Vitalhub shows how Vitalhub's AI push, contract structure and cash profile could be accelerating or quietly stalling the story.

High Tide (TSXV:HITI)

High Tide runs a cannabis retail and accessories group across Canada, the United States and overseas, with its healthcare angle coming from medical cannabis distribution and hemp derived CBD products for patients. Bricks and mortar outlets produced about CA$597 million in revenue plus CA$124 million of segment adjustments, and the stock has a market value near CA$340 million.

High Tide provides exposure to cannabis retail scale with a healthcare focus through licensed medical cannabis and CBD channels. The stock now combines that medical access profile with profitability improvements and additional bank funding capacity. The key consideration is how margins might respond if an unseen pressure on its capital structure changes.

If that capital pressure is quietly building, review the High Tide financial health report to see whether High Tide's balance sheet is cushioning risk or masking a sharper squeeze.

Seeking Alternatives Before The Crowd?

Fresh ideas move first. Breakout themes, shifting momentum and under the radar stories often get caught late once prices start flying. Check these curated lists now and get in early.

• Spot underfollowed cash machines before the crowd does by scanning a curated 5 high quality undervalued stocks. Act while these balance sheet standouts are still priced as if no one is watching.
• Ride real earnings power in AI, not hype, by zeroing in on a hand picked set of 40 profitable AI stocks that aren't just burning cash. Do not wait until the hype cycle cools.
• Explore potential compounding income streams by checking a curated group of 3 dividend fortresses. Review these ideas while yields remain elevated and attention stays elsewhere.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com